Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)<sub>2</sub>, in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2)

Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)<sub>2</sub>, in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2)

Overexpression of breast cancer resistance transporter (BCRP/ABCG2) in cancers has been explained for the failure of chemotherapy in clinic. Inhibition of the transport activity of BCRP during chemotherapy should reverse multidrug resistance. In this study, a triazole-bridged flavonoid dimer <b&g...

Full description

Bibliographic Details
Main Authors:	Tsz Cheung Chong, Iris L. K. Wong, Jiahua Cui, Man Chun Law, Xuezhen Zhu, Xuesen Hu, Jason W. Y. Kan, Clare S. W. Yan, Tak Hang Chan, Larry M. C. Chow
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	International Journal of Molecular Sciences
Subjects:	multidrug resistance breast cancer resistance protein BCRP ABCG2 flavonoid dimers
Online Access:	https://www.mdpi.com/1422-0067/23/21/13261

Similar Items

Expression of ABCG2 (BCRP) in mouse models with enhanced erythropoiesis
by: Gladys Oluyemisi Latunde-Dada, et al.
Published: (2014-06-01)

ABCG2 Overexpression Contributes to Pevonedistat Resistance
by: Rishil J. Kathawala, et al.
Published: (2020-02-01)

Enhanced reversal of ABCG2‐mediated drug resistance by replacing a phenyl ring in baicalein with a meta‐carborane
by: Lydia Kuhnert, et al.
Published: (2024-02-01)

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP
by: Sophie E. B. Ambjørner, et al.
Published: (2020-03-01)

Breast Cancer Resistance Protein (BCRP/<i>ABCG2</i>) Inhibits Extra Villous Trophoblast Migration: The Impact of Bacterial and Viral Infection
by: Phetcharawan Lye, et al.
Published: (2019-09-01)

ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches
by: Cleophas MC, et al.
Published: (2017-04-01)

Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter
by: Ziyong Xu, et al.
Published: (2023-01-01)

ABCG2/BCRP transport mechanism revealed through kinetically excited targeted molecular dynamics simulations
by: B. Dudas, et al.
Published: (2022-01-01)

Development of Simple and Accurate in Silico Ligand-Based Models for Predicting ABCG2 Inhibition
by: Shuheng Huang, et al.
Published: (2022-05-01)

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer
by: Jesper Andreas Palshof, et al.
Published: (2020-07-01)

Expression, Function and Trafficking of the Human ABCG2 Multidrug Transporter Containing Mutations in an Unstructured Cytoplasmic Loop
by: Orsolya Mózner, et al.
Published: (2023-10-01)

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
by: Kun Liu, et al.
Published: (2021-05-01)

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)
by: Juan Pablo Rigalli, et al.
Published: (2024-04-01)

Effects of High-Intensity Resistance Training and Aerobic Exercise on Expression of ABCG4, ABCG5 and ABCG8 Genes in Female Athletes
by: Reza Bagheri, et al.
Published: (2020-05-01)

Evaluation of mRNA Expression Profile of ABCG2/BCRP in Childhood Acute Lymphoblastic Leukemia
by: M Entezar-e-Ghaem, et al.
Published: (2013-12-01)

Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats
by: Sheena Sharma, et al.
Published: (2023-02-01)

TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression
by: Jing Hu, et al.
Published: (2020-06-01)

Comprehensive Analysis of <i>ABCG2</i> Genetic Variation in the Polish Population and Its Inter-Population Comparison
by: Marcin Słomka, et al.
Published: (2020-09-01)

Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2
by: Peng Xu, et al.
Published: (2018-10-01)

Identification of Specific Trafficking Defects of Naturally Occurring Variants of the Human ABCG2 Transporter
by: Zsuzsa Bartos, et al.
Published: (2021-02-01)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
by: Wei Zhang, et al.
Published: (2018-10-01)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
by: Ning Ji, et al.
Published: (2018-10-01)

Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood–brain barrier
by: Joanna R. Thomas, et al.
Published: (2024-03-01)

Noni increased the systemic exposure of methotrexate in rats through inhibition on multi-drug resistance protein 2 (MRP 2) and breast cancer resistance protein (BCRP)
by: Pei-Wen Hsu, et al.
Published: (2013-07-01)

Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor
by: Jing-Quan Wang, et al.
Published: (2020-12-01)

ABCG2 Single Nucleotide Polymorphism Affects Imatinib Pharmacokinetics in Lower Alpha-1-Acid Glycoprotein Levels in Humans
by: Jin-Woo Park, et al.
Published: (2021-04-01)

A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo
by: Shoji Kokubo, et al.
Published: (2021-11-01)

GSK2606414 Sensitizes ABCG2-Overexpressing Multidrug-Resistant Colorectal Cancer Cells to Chemotherapeutic Drugs
by: Ze-Zhong Yu, et al.
Published: (2023-11-01)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
by: Yongchao Zhang, et al.
Published: (2020-11-01)

Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells
by: Yao Chen, et al.
Published: (2024-01-01)

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration
by: Chung-Ping Yu, et al.
Published: (2021-12-01)

Double-Coated Poly(butyl Cyanoacrylate) Nanoparticles as a Potential Carrier for Overcoming P-Gp- and BCRP-Mediated Multidrug Resistance in Cancer Cells
by: Neeraj Kaushal, et al.
Published: (2021-10-01)

High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
by: Hao Shu, et al.
Published: (2021-01-01)

Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells
by: Yan-Qing Li, et al.
Published: (2022-10-01)

Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment
by: Danijela Mandić, et al.
Published: (2023-08-01)

Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
by: Yu Toyoda, et al.
Published: (2019-03-01)

Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy
by: Péter Szatmári, et al.
Published: (2023-08-01)

Potential modulation on BCRP and MRP 4 by onion: in vivo and ex-vivo studies
by: Yu-Chin Lin, et al.
Published: (2014-05-01)

ABCG2 is associated with HER-2 Expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma
by: Gao Peng, et al.
Published: (2011-09-01)

Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma
by: Xia Liao, et al.
Published: (2020-01-01)